Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Rory M. S. de Zanger
Maintaining Radiochemical Purity of [177Lu]Lu-Dota-Psma-617 for PRRT by Reducing Radiolysis
Journal of Radioanalytical and Nuclear Chemistry
Nuclear Medicine
Radiology
Mutagenesis
Nuclear Energy
Public Health
Analytical Chemistry
Environmental
Engineering
Health
Imaging
Spectroscopy
Toxicology
Occupational Health
Pollution
Related publications
Nephrotoxicity After PRRT With 177Lu-Dota-Octreotate
European Journal of Nuclear Medicine and Molecular Imaging
Medicine
Nuclear Medicine
Radiology
Imaging
Tumor Uptake in Glioblastoma Multiforme After IV Injection of [177Lu]Lu-Psma-617
European Journal of Nuclear Medicine and Molecular Imaging
Medicine
Nuclear Medicine
Radiology
Imaging
Predictors of Response to Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer With 177 Lu-Psma-617
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Salvage PRRT With 177Lu-Dota-Octreotate in Extensively Pretreated Patients With Metastatic Neuroendocrine Tumor (NET): Dosimetry, Toxicity, Efficacy, and Survival
BMC Cancer
Cancer Research
Oncology
Genetics
Clinical Outcome of Standardized 177Lu-Psma-617 Therapy in Metastatic Prostate Cancer Patients Receiving 7400 MBq Every 4 Weeks
European Journal of Nuclear Medicine and Molecular Imaging
Medicine
Nuclear Medicine
Radiology
Imaging
[ 177 Lu]-Psma-617 Radionuclide Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer – Author's Reply
The Lancet Oncology
Oncology
225Ac-Psma-617 for PSMA-Targeted -Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Determination of Radiochemical Purity of Radiomercury by Paper Chromatography
Bunseki Kagaku
Analytical Chemistry
Alpha-Pet for Prostate Cancer: Preclinical Investigation Using 149Tb-Psma-617
Scientific Reports
Multidisciplinary
